Home LiteratureArticle Details
PMID: 4105708 Published · ppublish English Clinical Trial Controlled Clinical Trial Journal Article

Low doses of heparin in prevention of deep-vein thrombosis.

Lancet (London, England) ·Vol. 2 ·No. 7726 ·1971-09-25 ·Pages 669-71

Kakkar VV, Field ES, Nicolaides AN, Flute PT

Abstract

暂无摘要

MeSH Terms
Age Factors Factor X/metabolism Heparin/administration & dosage Hernia, Inguinal/surgery Humans Injections, Intravenous Injections, Subcutaneous Iodine Radioisotopes Leg/blood supply Middle Aged Phlebography Postoperative Complications Thrombin/metabolism Thrombophlebitis/diagnosis,prevention & control Time Factors
Chemicals
Iodine Radioisotopes Factor X Heparin Thrombin
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Kakkar V V
Field E S
Nicolaides A N
Flute P T
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
DOI
10.1016/s0140-6736(71)92244-6
Published
1971-09-25
Pages
669-71
Language
English
Region
England
NLM ID
2985213R
Subset
IM
External Links
PubMed source DOI: 10.1016/s0140-6736(71)92244-6 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2